No allelic association between Parkinson's disease and dopamine D2, D3, and D4 receptor gene polymorphisms
- 15 December 1994
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics
- Vol. 54 (4) , 361-364
- https://doi.org/10.1002/ajmg.1320540415
Abstract
Parkinson's disease is thought to be caused by a combination of unknown environmental, genetic, and degenerative factors. Evidence from necropsy brain samples and pharmacokinetics suggests involvement of dopamine receptors in the pathogenesis or pathophysiology of Parkinson's disease. Genetic association studies between Parkinson's disease and dopamine D2, D3 and D4 receptor gene polymorphisms were conducted. The polymorphism was examined in 71 patients with Parkinson's disease and 90 controls. There were no significant differences between two groups in allele frequencies at the D2, D3, and D4 dopamine receptor loci. Our findings do not support the hypothesis that susceptibility to Parkinson's disease is associated with the dopamine receptor polymorphisms examined.Keywords
This publication has 34 references indexed in Scilit:
- A study of the association between schizophrenia and the dopamine D3 receptor geneHuman Genetics, 1993
- Dopamine D3 and D4 receptor gene polymorphisms and Parkinson's diseaseThe Lancet, 1993
- Association study of schizophrenia with D11S35 and dopamine D2 receptor gene loci using dinucleotide repeat polymorphismsPsychiatric Genetics, 1993
- Amino acid substitution in the dopamine D3 receptor as a useful polymorphism for investigating psychiatric disordersPsychiatric Genetics, 1992
- The D4 dopamine receptor (DRD4) maps to distal 11p close to HRASGenomics, 1992
- Mutant debrisoquine hydroxylation genes in Parkinson's diseaseThe Lancet, 1992
- Core assessment program for intracerebral transplantations (CAPIT)Movement Disorders, 1992
- Detection and characterization of additional DNA polymorphisms in the dopamine D2 receptor geneGenomics, 1991
- Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neurolepticsNature, 1990
- Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's DiseaseNew England Journal of Medicine, 1988